\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ elevated\\ liver\\ enzymes\\;\ \(0\)\
\-\ \\â\\€\\¢\\ elevated\\ total\\ bilirubin\\;\ \(0\)\
\-\ \\+\\ perinuclear\\ antineutrophil\\ cytoplasmic\\ antibodies\\ \\(panca\\)\ \(0\)\
\-\ medications\\ for\\ itching\\ and\\ infection\\;\\ vitamin\\ supplements\\ for\\ nutritional\\ deficiency\\;\\ the\\ patient\\ is\\ awaiting\\ liver\\ transplant\\.\ \(0\)\
\-\ contast\\-enhanced\\ axial\\ ct\\ image\\ demonstrates\\ nodular\\ appearance\\ of\\ the\\ surface\\ of\\ the\\ liver\\,\\ atrophy\\ of\\ the\\ lateral\\ and\\ posterior\\ segments\\,\\ hypertrophy\\ of\\ the\\ caudate\\ lobe\\,\\ and\\ overall\\ rounded\\ appearance\\ to\\ the\\ liver\\,\\ all\\ concerning\\ for\\ cirrhosis\\.\\ \\ the\\ spleen\\ is\\ enlarged\\.\\ \\ there\\ is\\ thickening\\ of\\ the\\ wall\\ of\\ the\\ colon\\.\\ \\ mrcp\\ image\\ \\(obtained\\ 5\\ years\\ earlier\\)demonstrates\\ a\\ beaded\\ appearance\\ to\\ the\\ intrahepatic\\ ducts\\.\ \(0\)\
\-\ primary\\ sclerosing\\ cholangitis\\ with\\ ulcerative\\ colitis\ \(0\)\
\-\ sclerosing\\ cholangitis\\ with\\ ulcerative\\ colitis\ \(0\)\
\-\ secondary\\ cholangitis\\ with\\ infectious\\ colitis\ \(0\)\
\-\ \\ \\(eg\\.\\ aids\\)\ \(0\)\
\-\ diffuse\\ cholangiocarcinoma\ \(0\)\
\-\ pseudocirrhosis\\ from\\ metastatic\\ disease\ \(0\)\
\-\ 47\\ y\\.o\\.\\ man\\ with\\ vague\\ abdominal\\ pain\\ and\\ jaundice\ \(1\)\
\-\ charatcharoenwitthaya\\ p\\,\\ lindor\\ kd\\ \\(feb\\ 2006\\)\\.\\ \\"primary\\ sclerosing\\ cholangitis\\:\\ diagnosis\\ and\\ management\\"\\.\\ curr\\ gastroenterol\\ rep\\ 8\\ \\(1\\)\\:\\ 75\\â\\€\\“82\\.\ \(0\)\
\-\ dodd\\ et\\.\\ al\\.\\,\\ end\\-stage\\ primary\\ sclerosing\\ cholangitis\\:\\ ct\\ findings\\ of\\ hepatic\\ morphology\\ in\\ 36\\ patients\\.\\ \\ radiology\\ 1999\\;\\ 211\\:357\\-362\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cholangitis\\:\\ 0\\.42176370781653383\ \(0\)\
\-\ sclerosing\\:\\ 0\\.3073470053739085\ \(0\)\
\-\ colitis\\:\\ 0\\.21640403480476492\ \(0\)\
\-\ liver\\:\\ 0\\.20127321159389627\ \(0\)\
\-\ ulcerative\\:\\ 0\\.16404281512288918\ \(0\)\
\-\ the\\:\\ 0\\.14554438962692626\ \(0\)\
\-\ primary\\:\\ 0\\.13455315290123399\ \(0\)\
\-\ appearance\\:\\ 0\\.13192050803045663\ \(0\)\
\-\ perinuclear\\:\\ 0\\.11664907103469001\ \(0\)\
\-\ panca\\:\\ 0\\.11664907103469001\ \(0\)\
\-\ pseudocirrhosis\\:\\ 0\\.11664907103469001\ \(0\)\
\-\ charatcharoenwitthaya\\:\\ 0\\.11664907103469001\ \(0\)\
\-\ lindor\\:\\ 0\\.11664907103469001\ \(0\)\
\-\ dodd\\:\\ 0\\.11664907103469001\ \(0\)\
\-\ antineutrophil\\:\\ 0\\.10493252047219384\ \(0\)\
\-\ curr\\:\\ 0\\.10493252047219384\ \(0\)\
\-\ rep\\:\\ 0\\.10493252047219384\ \(0\)\
\-\ gastroenterol\\:\\ 0\\.10260118647033166\ \(0\)\
\-\ itching\\:\\ 0\\.10063007165751996\ \(0\)\
\-\ kd\\:\\ 0\\.10063007165751996\ \(0\)\
\-\ of\\:\\ 0\\.09992007226630875\ \(0\)\
\-\ elevated\\:\\ 0\\.09945015618012269\ \(0\)\
\-\ supplements\\:\\ 0\\.09892261434190823\ \(0\)\
\-\ cytoplasmic\\:\\ 0\\.09606929212580294\ \(0\)\
\-\ beaded\\:\\ 0\\.09606929212580294\ \(0\)\
\-\ nutritional\\:\\ 0\\.09485056699637388\ \(0\)\
\-\ image\\:\\ 0\\.09329732662721492\ \(0\)\
\-\ mrcp\\:\\ 0\\.09088463590783549\ \(0\)\
\-\ antibodies\\:\\ 0\\.09005938599551734\ \(0\)\
\-\ awaiting\\:\\ 0\\.085987338649983\ \(0\)\
\-\ caudate\\:\\ 0\\.08541893682550096\ \(0\)\
\-\ feb\\:\\ 0\\.08385122883075116\ \(0\)\
\-\ enzymes\\:\\ 0\\.08336864568800587\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.08119615764912644\ \(0\)\
\-\ aids\\:\\ 0\\.07933972464163697\ \(0\)\
\-\ bilirubin\\:\\ 0\\.07834283543302116\ \(0\)\
\-\ eg\\:\\ 0\\.07771895874677072\ \(0\)\
\-\ jaundice\\:\\ 0\\.07771895874677072\ \(0\)\
\-\ morphology\\:\\ 0\\.07771895874677072\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.07683675134347713\ \(0\)\
\-\ vitamin\\:\\ 0\\.07655570847911007\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.07655570847911007\ \(0\)\
\-\ and\\:\\ 0\\.075362167359779\ \(0\)\
\-\ ducts\\:\\ 0\\.0752362982973331\ \(0\)\
\-\ segments\\:\\ 0\\.07404038661834728\ \(0\)\
\-\ 1999\\:\\ 0\\.07337309075427768\ \(0\)\
\-\ demonstrates\\:\\ 0\\.07328986517917385\ \(0\)\
\-\ transplant\\:\\ 0\\.07294682009579469\ \(0\)\
\-\ 2006\\:\\ 0\\.07273889786288389\ \(0\)\
\-\ deficiency\\:\\ 0\\.07137105226114261\ \(0\)\
\-\ vague\\:\\ 0\\.07137105226114261\ \(0\)\
\-\ spleen\\:\\ 0\\.07100568638835128\ \(0\)\
\-\ concerning\\:\\ 0\\.06996833927281293\ \(0\)\
\-\ atrophy\\:\\ 0\\.06900886918380716\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.06870440395280437\ \(0\)\
\-\ overall\\:\\ 0\\.06701576479449868\ \(0\)\
\-\ 47\\:\\ 0\\.06688461558756811\ \(0\)\
\-\ earlier\\:\\ 0\\.06662628487052498\ \(0\)\
\-\ rounded\\:\\ 0\\.0663730699509422\ \(0\)\
\-\ for\\:\\ 0\\.06632387480264136\ \(0\)\
\-\ medications\\:\\ 0\\.06118841373297475\ \(0\)\
\-\ surface\\:\\ 0\\.06085840998333348\ \(0\)\
\-\ 36\\:\\ 0\\.0603788436945792\ \(0\)\
\-\ is\\:\\ 0\\.05992643891723049\ \(0\)\
\-\ total\\:\\ 0\\.05976617870179725\ \(0\)\
\-\ infectious\\:\\ 0\\.058691013298525545\ \(0\)\
\-\ radiology\\:\\ 0\\.05841894057523598\ \(0\)\
\-\ nodular\\:\\ 0\\.058086793703896626\ \(0\)\
\-\ hepatic\\:\\ 0\\.058086793703896626\ \(0\)\
\-\ et\\:\\ 0\\.05713917983788365\ \(0\)\
\-\ with\\:\\ 0\\.05713129970610185\ \(0\)\
\-\ ct\\:\\ 0\\.0555389007018972\ \(0\)\
\-\ colon\\:\\ 0\\.0555387267917396\ \(0\)\
\-\ management\\:\\ 0\\.053878366897997285\ \(0\)\
\-\ obtained\\:\\ 0\\.05159430443086573\ \(0\)\
\-\ enlarged\\:\\ 0\\.049725078090061346\ \(0\)\
\-\ thickening\\:\\ 0\\.04962318961805402\ \(0\)\
\-\ diffuse\\:\\ 0\\.045743244263562875\ \(0\)\
\-\ years\\:\\ 0\\.04471206116839154\ \(0\)\
\-\ wall\\:\\ 0\\.04437105601087763\ \(0\)\
\-\ infection\\:\\ 0\\.04406078585245636\ \(0\)\
\-\ all\\:\\ 0\\.04342023780063497\ \(0\)\
\-\ secondary\\:\\ 0\\.04323416754850743\ \(0\)\
\-\ lobe\\:\\ 0\\.042152382963194554\ \(0\)\
\-\ axial\\:\\ 0\\.04213353707093773\ \(0\)\
\-\ patients\\:\\ 0\\.041033489039968105\ \(0\)\
\-\ metastatic\\:\\ 0\\.040004672385097986\ \(0\)\
\-\ abdominal\\:\\ 0\\.03989354996127594\ \(0\)\
\-\ man\\:\\ 0\\.038616047402398636\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03781227009895781\ \(0\)\
\-\ posterior\\:\\ 0\\.037718592496232224\ \(0\)\
\-\ to\\:\\ 0\\.03647038000300832\ \(0\)\
\-\ lateral\\:\\ 0\\.036199181739946115\ \(0\)\
\-\ findings\\:\\ 0\\.03599947358785454\ \(0\)\
\-\ disease\\:\\ 0\\.030618180383279767\ \(0\)\
\-\ there\\:\\ 0\\.029023130077506204\ \(0\)\
\-\ from\\:\\ 0\\.028969205124284966\ \(0\)\
\-\ pain\\:\\ 0\\.026101093327497483\ \(0\)\
\-\ patient\\:\\ 0\\.02372415392642952\ \(0\)\
\-\ in\\:\\ 0\\.01814543643408313\ \(0\)\
